A promising strategy to increase activity in antimicrobial peptides

April 4, 2017
Credit: Institut national de la recherche scientifique

In an article published recently in Plos One, researchers from INRS-Institut Armand-Frappier Research Centre reported a strategy that could lead to the discovery of new cationic antimicrobial peptides (CAMPs) with greatly enhanced antimicrobial properties. The peptide modified for the study retained considerable activity against biofilms responsible for increasing the severity of various infections. The strategy thus holds promise for combating multidrug-resistant bacteria.

For the purpose of the study, the researchers selected a peptide—pep1037—already known for its antimicrobial potential and antibiofilm activity against Pseudomonas aeruginosa and Burkholderia, two pathogens responsible for serious complications in individuals with cystic fibrosis. The peptide was modified by adding a cysteine to the end to generate a dimer. The of the new molecule was 60 times greater than that of the original peptide.

"Our results show that the dimer is of significant interest because it has a dual potential to inhibit both bacterial and biofilm growth. It could potentially be used for therapy in combination with clinically relevant antibiotics," explained the authors of the study.

Although there are currently no clinically approved antimicrobials that target , an estimated 80 percent of all bacterial infections have a biofilm component. These infections are much more difficult to eradicate because they are 10-1,000 times more resistant to antibiotic treatment. The formation of biofilms is associated with severe antibiotic resistance in the lungs of patients with , among others.

To date, very few studies have reported on the effect of dimerizing cationic antimicrobial peptides by adding a cysteine, especially at the specific location modified by the researchers, i.e., at the end.

The results obtained pave the way to improving this class of antibiotics, which occur naturally in many organisms.

Explore further: Phage therapy shown to kill drug-resistant superbug

More information: Amal Thamri et al, Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity, PLOS ONE (2017). DOI: 10.1371/journal.pone.0173783

Related Stories

Phage therapy shown to kill drug-resistant superbug

March 13, 2017

Scientists from the University of Liverpool's Institute of Infection and Global Health have shown that phage therapy could offer a safe and effective alternative to antibitotics in the treatment of cystic fibrosis lung infections.

Antimicrobial substances identified in Komodo dragon blood

February 22, 2017

In a land where survival is precarious, Komodo dragons thrive despite being exposed to scads of bacteria that would kill less hardy creatures. Now in a study published in the Journal of Proteome Research, scientists report ...

Recommended for you

Stiff fibres spun from slime

October 17, 2017

Nature is an excellent teacher – even for material scientists. Researchers, including scientists at the Max Planck Institute of Colloids and Interfaces, have now observed a remarkable mechanism by which polymer materials ...

A new way to harness wasted methane

October 17, 2017

Methane gas, a vast natural resource, is often disposed of through burning, but new research by scientists at MIT could make it easier to capture this gas for use as fuel or a chemical feedstock.

Key to expanding genetic code described

October 17, 2017

Yale scientists have described the atomic structure of a protein that is the key tool in efforts by synthetic biologists to expand the genetic code.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.